Market Insights
ImmunityBio (IBRX) Surges Nearly 12% On Promising Clinical Trial Progress
ImmunityBio, Inc. (NASDAQ: IBRX) saw a significant uptick in its stock price, climbing 11.97% to $5.24 in the previous trading session, driven by advancements in